CHYM: 93,000 RSUs Award Raises Insider Stake to 317,336

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) officer Asmerom Amine reported the acquisition of 93,000 restricted stock units (RSUs) on 10/09/2025. Each RSU represents a contingent right to one share of Class A common stock and was reported at a $0 price because RSUs are equity awards, not open-market purchases. After the award, the reporting person beneficially owns 317,336 shares/RSU-equivalents. The filing states 11/15/2025 as the first vesting date for one-sixteenth of the RSUs, with quarterly vesting thereafter, subject to continued service. The disclosure was signed by power of attorney on 10/10/2025.

Positive

• Significant equity alignment: 93,000 RSUs grant increases insider ownership to 317,336 units
• Multi-period vesting: one-sixteenth vests on 11/15/2025, then quarterly, supporting retention over time

Negative

• None.

Insights

Corporate Governance Analyst

Officer received a sizeable RSU grant with multi-quarter vesting that ties compensation to shareholder value.

The 93,000 RSU award increases the reporting person's stake to 317,336 shares on a beneficial basis, aligning incentives between management and shareholders because each RSU converts to one Class A share on vesting.

Vesting begins on 11/15/2025 with one-sixteenth vesting and then quarterly thereafter, so the award vests over approximately four years if service continues; monitor quarterly vesting events and any subsequent sales or additional grants in the next 4 years.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Asmerom Amine

(Last) (First) (Middle)

C/O CHIME FINANCIAL, INC.

101 CALIFORNIA STREET, SUITE 500

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/09/2025		A		93,000(1)	A	$0	317,336(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. One-sixteenth (1/16th) of the RSUs shall vest on November 15, 2025 and quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date.

2. Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Remarks:

	/s/ Theresa Bloom, by power of attorney	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Asmerom Amine report on the Form 4 for CHYM?

The report discloses an award of 93,000 restricted stock units (RSUs) acquired on 10/09/2025, bringing beneficial ownership to 317,336 shares/RSU-equivalents.

When do the RSUs begin to vest for CHYM insider Asmerom Amine?

Vesting begins on 11/15/2025 when one-sixteenth of the RSUs vest, with quarterly vesting thereafter, subject to continued service.

Why is the price listed as $0 on the Form 4?

The price is $0 because the reported securities are RSUs (equity awards), not open-market purchases with an exchange price.

How many total RSUs or shares does the reporting person own after the transaction?

After the reported award, the reporting person beneficially owns 317,336 shares or RSU-equivalents.

Who signed the Form 4 and when was it filed?

The form was signed by Theresa Bloom by power of attorney on 10/10/2025.